Brian Leber

Juravinski Hospital And Cancer Centre 711 Concession Street, L8V1C3
Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 107 publications

Chimerism practices across Canadian transplant centres: review of current standards and variations.

Chimerism practices across Canadian transplant centres: review of current standards and variations.

Journal: Frontiers in transplantation

Published: May 12, 2026

Controversies in the Management of AML in Older Patients: A Canadian Perspective.

Controversies in the Management of AML in Older Patients: A Canadian Perspective.

Journal: Current oncology (Toronto, Ont.)

Published: May 07, 2026

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Journal: Current oncology (Toronto, Ont.)

Published: May 07, 2026

Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.

Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.

Journal: Blood cancer journal

Published: March 02, 2026

Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia.

Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia.

Journal: Leukemia & lymphoma

Published: November 06, 2025

Red blood cell transfusion thresholds in acute leukemia: Current practice and physician perspectives from a national survey.

Red blood cell transfusion thresholds in acute leukemia: Current practice and physician perspectives from a national survey.

Journal: Transfusion

Published: October 28, 2025

Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.

Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.

Journal: Blood cancer journal

Published: July 18, 2025

High-content imaging of primary chronic lymphocytic leukemia cells predicts patient cohorts with distinct cellular drug responses.

High-content imaging of primary chronic lymphocytic leukemia cells predicts patient cohorts with distinct cellular drug responses.

Journal: iScience

Published: June 12, 2025

Allogeneic Stem Cell Transplantation: The Relevance of Conditioning Regime Intensity for Myelodysplastic Syndromes (MDS).

Allogeneic Stem Cell Transplantation: The Relevance of Conditioning Regime Intensity for Myelodysplastic Syndromes (MDS).

Journal: Current oncology (Toronto, Ont.)

Published: April 22, 2025

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Journal: Haematologica

Published: March 07, 2025

A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML.

A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML.

Journal: Future oncology (London, England)

Published: March 07, 2025

Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.

Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.

Journal: British journal of haematology

Published: February 24, 2025

Showing 1-12 of 107

Last Updated: 09/26/2026